In an era of consequential transformation in the healthcare delivery, compounding pharmacies market is charting a profitable growth curve.
Although a major chunk of pharmacists is involved in drug manufacturing, yet with the advancement of technology compounding has become an integral of pharmacy practice. The expanding geriatric population base along with increasing customized medication requirements subject to alternative doses, flavor and formulations are stimulating the market dynamics. In addition to this, the recent trend toward personalized diagnostic approach is expected to complement the business landscape in the years ahead.
With the increasing drug shortage issues and drug failure rates in recent times, compounding pharmacies are anticipated to be the best alternative to address the growing drug demand. As per a report by Global Market Insights, “ Compounding pharmacies market will hold a valuation of more than $12 billion by 2024, with an estimated compound annual growth rate (CAGR) of 5% over 2017-2024.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze